Coronavirus

There has been more attention been paid to the pulmonary complications of COVID-19, with less attention being paid to the cardiovascular complications that can result in death or impairment.

Critical care drug products are being introduced in the United States to help ease shortages due to the COVID-19 pandemic.

Top news of the week from Pharmacy Times®.

What characteristics of RA treatments possibly connect to COVID-19 treatment?

Pharmacy Times® interviewed Benjamin McNabb, PharmD, the owner of Love Oak Pharmacy, about how pharmacies can protect the communities they serve during the COVID-19 pandemic when reopening or staying open across the country.

Allison Hanson, PharmD, BCPS, the 2019-2020 Institute for Safe Medication Practices (ISMP) International Medication Safety Management Fellow, discusses medication safety during the COVID-19 pandemic.

According to a new survey released by the NCPA, COVID-19 is changing how local pharmacies do business across the country, and these changes may be for the long term.

Pharmacy Times® interviewed Benjamin McNabb, PharmD, the owner of Love Oak Pharmacy, about the path ahead in managing COVID-19 guidelines and supporting safe practices in pharmacies when reopening.

Consumers report a very high level of comfort with COVID-19 testing at community pharmacies and was similar to the level of comfort respondents reported among hospitals and urgent care facilities.

Nearly half of community pharmacies offer long-term care services and play a critical role in ensuring patients have immediate access to medications in long-term care settings.

The FDA granted an Emergency Use Authorization for the drug in hospitalized patients with severe COVID-19, but the authorization does not take the place of a formal new drug approval process.

Consider these 5 takeaways from a pharmacy leader in an academic health care system during the COVID-19 crisis.

A new law approved in Minnesota this week expands pharmacists’ authority by allowing them to administer FDA-authorized COVID-19 or SARS-CoV-2 vaccines when they become available.

Treatment of COVID-19 with both hydroxychloroquine and azithromycin also was strongly associated with increased risk of death.

Pharmacy Times® interviewed James Krellenstein, co-Founder, PrEP4All Collaboration and Organizer, The COVID-19 Working Group, to discuss the development of PrEP for the COVID-19 pandemic.

New York Governor Andrew Cuomo announced last week that New York will launch a COVID-19 testing pilot program with a goal of conducting 7000 tests per week.

A study released today demonstrated that tocilizumab has been shown to significantly improve survival outcomes for patients with COVID-19.

Pharmacists are routinely putting others ahead of themselves and may not be sure how to find time for self-care.

Pharmacy Times spoke with Ron Lanton III, Esq, a regulatory and government affairs professional, about how COVID-19 could lead to more expanded practice laws for pharmacists across the country.

As we consider the implications of the COVID-19 pandemic and the release of remdesivir, ICER’s expedited evaluation raises some questions related to value-based pricing evaluations.

Although most children admitted to pediatric ICUs for COVID-19 had underlying conditions, children, teens, and young adults are at a greater risk for severe complications than researchers had previously believed.

Haziness around the volume of products and locations of facilities hampers management of shortages, experts say.

Four case studies about skin and eye health.

Elizabeth Skoy, PharmD and Amy Werremeyer, PharmD, BCPP, discuss what patients wish their pharmacists knew about mental health.

Because of continuing social distancing policies and stay-at-home orders, many families have been unable to grieve their family members at funerals or other family gatherings.

Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

Mental health first aid trains participants to recognize risk factors and warning signs for mental health and addiction concerns.

The online resource center will host a webinar series and provide comprehensive coverage and updates on COVID-19 through Pharmacy Times®.

John Beckner, RPh, Senior Director of Strategic Initiatives at NCPA, discusses the role of the community pharmacy in the age of COVID-19 in supporting current health care efforts, such as continuing immunizations and managing the effects of the pandemic on patients.

The Secretary of HHS, Alex M. Azar II, clarified in a statement that the PREP Act preempts state licensing laws that place restrictions on pharmacists’ ability to order and administer COVID-19 tests.